This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Thiagarajan, P. Search for Related Content PubMed PubMed Citation Articles by Thiagarajan, P.

(Circulation. 2001;104:1876.)
© 2001 American Heart Association, Inc.

Editorial

Atherosclerosis, Autoimmunity, and Systemic Lupus Erythematosus

Perumal Thiagarajan, MD

From the Department of Medicine, University of Texas Health Science Center, Houston, Tex.

Correspondence to Perumal Thiagarajan, MD, University of Texas Health Sciences Center, 6431 Fannin St, MSB 5.284, Houston TX 77030. E-mail Perumal.Thiagarajan@uth.tmc.edu

Key Words: Editorials • cardiovascular diseases • risk factors • atherosclerosis

Atherosclerosis can be considered a chronic inflammatory condition of the vessel wall. Fatty streaks, the earliest morphological lesions of atherosclerosis, are caused by lipids (primarily of cholesteryl esters) accumulated within the macrophages (foam cells) and smooth muscle cells in the intimal layer. These lesions progress into atherosclerotic plaques containing extracellular matrix components, smooth muscle cells, macrophages, connective tissues, lymphocytes, and a fibrous cap over a pool of extracellular lipid. The primary pathogenic event in atherosclerosis is not clear. The "response to injury hypothesis" postulates that long-term endothelial cell injury, from a variety of mechanisms, alters endothelial permeability and induces leukocyte and platelet adhesion.¹ The release of mitogenic factors from platelets and leukocytes was proposed to induce the migration and proliferation of smooth muscle cells from the media. The "lipid hypothesis" proposes that the retention and oxidation of LDL in the subendothelium play a central role in the atherosclerotic process.^2,3 The uptake of oxidatively modified LDL by the macrophage via the scavenger receptor induces foam cell formation, but unmodified native LDL has no effect. Products of LDL oxidation, such as oxidized cholesterol, phospholipids, and isoprostanes have been detected in atherosclerotic plaques.⁴ Oxidized LDL has a number of pro-atherogenic effects, such as being chemotactic to monocytes and T cells, promoting inflammatory gene expression in vascular cells, and inducing the expression of the macrophage scavenger receptor.⁵

See p 1887

Many genetic, environmental, inflammatory, and hemodynamic factors seem to modify the progression of the fatty steak to an advanced atherosclerotic plaque. In recent years, . . . [Full Text of this Article]

This article has been cited by other articles:

				A Liu, W Zhang, X Tian, X Zhang, F Zhang, and X Zeng Prevalence, risk factors and outcome of digital gangrene in 2684 lupus patients Lupus, October 1, 2009; 18(12): 1112 - 1118. [Abstract] [PDF]

				N. Braun, N. Wade, E. Wakeland, and A. Major Accelerated atherosclerosis is independent of feeding high fat diet in systemic lupus erythematosus-susceptible LDLr-/- mice Lupus, December 1, 2008; 17(12): 1070 - 1078. [Abstract] [PDF]

				J. Kazmierczak, M. Peregud-Pogorzelska, and I. Brzosko Coronary Stenosis Treated by Percutaneous Angioplasty in a Patient With Dermatomyositis Angiology, March 1, 2008; 59(1): 117 - 120. [Abstract] [PDF]

				Z Szekanecz and Y Shoenfeld Lupus and cardiovascular disease: the facts Lupus, November 1, 2006; 15(11_suppl): 3 - 10. [Abstract] [PDF]